Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMD114728: GSK256073 in type 2 diabetes mellitus on metformin
2011-000483-94Phase 2Completed
- Sponsor
- GSK
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GSK256073 in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by GSK. Primary endpoint: Safety and tolerability. Started May 2011; status: completed.
02
Drugs
GSK256073
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-000483-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000483-94.